We evaluated the effectiveness of probiotics, including strains like Lactobacillus rhamnosus and Saccharomyces boulardii, in preventing antibiotic-associated diarrhea (AAD) in children. Our review covered 23 diverse studies involving nearly 4,000 young participants.
The results were promising: probiotics reduced the incidence of AAD from 19% to 8%. While results were generally optimistic, with no serious side effects reported, moderate evidence suggests further studies are needed before fully endorsing probiotics for all pediatric patients.
Read More
We explored the effects of Saccharomyces cerevisiae on patients suffering from Irritable Bowel Syndrome (IBS). In a four-week study with thirty participants, we found that daily 500 mg doses of this yeast led to significant reductions in abdominal pain and improvements in overall quality of life.
Results showed pain scores decreased dramatically, and all quality of life measures improved after treatment. This suggests that Saccharomyces cerevisiae could be an effective option for those looking to alleviate IBS symptoms.
Read More
We examined how TRANSITECH, a food supplement made from plants and lactic ferments, affects constipation in healthy adults. Over a 10-day period, participants took either TRANSITECH or a placebo.
After monitoring their bowel movements, colonic transit time (CTT), and bloating, we found that TRANSITECH significantly increased their bowel movements and improved transit times without causing discomfort.
Impressively, these benefits continued even after participants stopped using the supplement.
Read More
We investigated the effects of brewer's yeast cell wall (BYC) on constipation in male rats induced by a medication called loperamide. In our findings, rats that received BYC showed significantly better defecation compared to those on a non-fiber diet or a cellulose-based diet. This improvement also included higher fecal water content and volatile fatty acids in the cecal contents. These results suggest that BYC can be beneficial in alleviating constipation by enhancing fermentation and water retention in the digestive system.
Read More
Saccharomyces boulardii improves constipationAPPLICATION OF THE SACCHAROMYCES BOULARDII PROBIOTIC COMPLEX IN THE CORRECTION OF INTRAINTESTINAL HOMEOSTASIS IN PATIENTS WITH DYSBIOTIC DISORDERS DUE TO ANTIBIOTIC THERAPY.
Study shows positive clinical outcomes
We examined how Saccharomyces boulardii, a probiotic, can help patients experiencing constipation and other symptoms of dysbiosis. Over a two-year period, 209 patients were treated; those given this probiotic showed significant improvements.
Most reported a reduction in stool frequency and alleviation of discomfort, such as flatulence and abdominal pain. In fact, 92.9% of the 141 patients in the main treatment group experienced a noticeable improvement after the treatment course.
Overall, the findings suggest that Saccharomyces boulardii can effectively enhance intestinal health in individuals affected by gastrointestinal disorders, including constipation.
Read More